These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33951425)

  • 21. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
    McGuire AT; Glenn JA; Lippy A; Stamatatos L
    J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires.
    Tian M; Cheng C; Chen X; Duan H; Cheng HL; Dao M; Sheng Z; Kimble M; Wang L; Lin S; Schmidt SD; Du Z; Joyce MG; Chen Y; DeKosky BJ; Chen Y; Normandin E; Cantor E; Chen RE; Doria-Rose NA; Zhang Y; Shi W; Kong WP; Choe M; Henry AR; Laboune F; Georgiev IS; Huang PY; Jain S; McGuire AT; Georgeson E; Menis S; Douek DC; Schief WR; Stamatatos L; Kwong PD; Shapiro L; Haynes BF; Mascola JR; Alt FW
    Cell; 2016 Sep; 166(6):1471-1484.e18. PubMed ID: 27610571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies.
    Briney B; Sok D; Jardine JG; Kulp DW; Skog P; Menis S; Jacak R; Kalyuzhniy O; de Val N; Sesterhenn F; Le KM; Ramos A; Jones M; Saye-Francisco KL; Blane TR; Spencer S; Georgeson E; Hu X; Ozorowski G; Adachi Y; Kubitz M; Sarkar A; Wilson IA; Ward AB; Nemazee D; Burton DR; Schief WR
    Cell; 2016 Sep; 166(6):1459-1470.e11. PubMed ID: 27610570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humanized V(D)J-rearranging and TdT-expressing mouse vaccine models with physiological HIV-1 broadly neutralizing antibody precursors.
    Luo S; Jing C; Ye AY; Kratochvil S; Cottrell CA; Koo JH; Chapdelaine Williams A; Francisco LV; Batra H; Lamperti E; Kalyuzhniy O; Zhang Y; Barbieri A; Manis JP; Haynes BF; Schief WR; Batista FD; Tian M; Alt FW
    Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2217883120. PubMed ID: 36574685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions.
    Caniels TG; Medina-Ramírez M; Zhang J; Sarkar A; Kumar S; LaBranche A; Derking R; Allen JD; Snitselaar JL; Capella-Pujol J; Sánchez IDM; Yasmeen A; Diaz M; Aldon Y; Bijl TPL; Venkatayogi S; Martin Beem JS; Newman A; Jiang C; Lee WH; Pater M; Burger JA; van Breemen MJ; de Taeye SW; Rantalainen K; LaBranche C; Saunders KO; Montefiori D; Ozorowski G; Ward AB; Crispin M; Moore JP; Klasse PJ; Haynes BF; Wilson IA; Wiehe K; Verkoczy L; Sanders RW
    Cell Rep Med; 2023 Apr; 4(4):101003. PubMed ID: 37044090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens.
    Abbott RK; Lee JH; Menis S; Skog P; Rossi M; Ota T; Kulp DW; Bhullar D; Kalyuzhniy O; Havenar-Daughton C; Schief WR; Nemazee D; Crotty S
    Immunity; 2018 Jan; 48(1):133-146.e6. PubMed ID: 29287996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor.
    Kong L; Ju B; Chen Y; He L; Ren L; Liu J; Hong K; Su B; Wang Z; Ozorowski G; Ji X; Hua Y; Chen Y; Deller MC; Hao Y; Feng Y; Garces F; Wilson R; Dai K; O'Dell S; McKee K; Mascola JR; Ward AB; Wyatt RT; Li Y; Wilson IA; Zhu J; Shao Y
    Immunity; 2016 Apr; 44(4):939-50. PubMed ID: 27067056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles.
    Melo M; Porter E; Zhang Y; Silva M; Li N; Dobosh B; Liguori A; Skog P; Landais E; Menis S; Sok D; Nemazee D; Schief WR; Weiss R; Irvine DJ
    Mol Ther; 2019 Dec; 27(12):2080-2090. PubMed ID: 31515132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.
    Beltran-Pavez C; Bontjer I; Gonzalez N; Pernas M; Merino-Mansilla A; Olvera A; Miro JM; Brander C; Alcami J; Sanders RW; Sanchez-Merino V; Yuste E
    J Virol; 2022 Jan; 96(1):e0134321. PubMed ID: 34668778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice.
    McGuire AT; Gray MD; Dosenovic P; Gitlin AD; Freund NT; Petersen J; Correnti C; Johnsen W; Kegel R; Stuart AB; Glenn J; Seaman MS; Schief WR; Strong RK; Nussenzweig MC; Stamatatos L
    Nat Commun; 2016 Feb; 7():10618. PubMed ID: 26907590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV Broadly Neutralizing Antibodies: VRC01 and Beyond.
    Wu X
    Adv Exp Med Biol; 2018; 1075():53-72. PubMed ID: 30030789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in Allelic Frequency and CDRH3 Region Limit the Engagement of HIV Env Immunogens by Putative VRC01 Neutralizing Antibody Precursors.
    Yacoob C; Pancera M; Vigdorovich V; Oliver BG; Glenn JA; Feng J; Sather DN; McGuire AT; Stamatatos L
    Cell Rep; 2016 Nov; 17(6):1560-1570. PubMed ID: 27806295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies.
    Lynch RM; Wong P; Tran L; O'Dell S; Nason MC; Li Y; Wu X; Mascola JR
    J Virol; 2015 Apr; 89(8):4201-13. PubMed ID: 25631091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo Activation.
    Dai K; Khan SN; Wang Y; He L; Guenaga J; Ingale J; Sundling C; O'Dell S; McKee K; Phad G; Corcoran M; Wilson R; Mascola JR; Zhu J; Li Y; Karlsson Hedestam GB; Wyatt RT
    Sci Rep; 2016 Feb; 6():20987. PubMed ID: 26879974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design.
    Jardine JG; Sok D; Julien JP; Briney B; Sarkar A; Liang CH; Scherer EA; Henry Dunand CJ; Adachi Y; Diwanji D; Hsueh J; Jones M; Kalyuzhniy O; Kubitz M; Spencer S; Pauthner M; Saye-Francisco KL; Sesterhenn F; Wilson PC; Galloway DM; Stanfield RL; Wilson IA; Burton DR; Schief WR
    PLoS Pathog; 2016 Aug; 12(8):e1005815. PubMed ID: 27560183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain.
    Gray MD; Feng J; Weidle CE; Cohen KW; Ballweber-Fleming L; MacCamy AJ; Huynh CN; Trichka JJ; Montefiori D; Ferrari G; Pancera M; McElrath MJ; Stamatatos L
    Sci Adv; 2022 May; 8(18):eabm3948. PubMed ID: 35507661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies.
    Hwang JK; Wang C; Du Z; Meyers RM; Kepler TB; Neuberg D; Kwong PD; Mascola JR; Joyce MG; Bonsignori M; Haynes BF; Yeap LS; Alt FW
    Proc Natl Acad Sci U S A; 2017 Aug; 114(32):8614-8619. PubMed ID: 28747530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination induces HIV broadly neutralizing antibody precursors in humans.
    Leggat DJ; Cohen KW; Willis JR; Fulp WJ; deCamp AC; Kalyuzhniy O; Cottrell CA; Menis S; Finak G; Ballweber-Fleming L; Srikanth A; Plyler JR; Schiffner T; Liguori A; Rahaman F; Lombardo A; Philiponis V; Whaley RE; Seese A; Brand J; Ruppel AM; Hoyland W; Yates NL; Williams LD; Greene K; Gao H; Mahoney CR; Corcoran MM; Cagigi A; Taylor A; Brown DM; Ambrozak DR; Sincomb T; Hu X; Tingle R; Georgeson E; Eskandarzadeh S; Alavi N; Lu D; Mullen TM; Kubitz M; Groschel B; Maenza J; Kolokythas O; Khati N; Bethony J; Crotty S; Roederer M; Karlsson Hedestam GB; Tomaras GD; Montefiori D; Diemert D; Koup RA; Laufer DS; McElrath MJ; McDermott AB; Schief WR
    Science; 2022 Dec; 378(6623):eadd6502. PubMed ID: 36454825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core.
    Borst AJ; Weidle CE; Gray MD; Frenz B; Snijder J; Joyce MG; Georgiev IS; Stewart-Jones GB; Kwong PD; McGuire AT; DiMaio F; Stamatatos L; Pancera M; Veesler D
    Elife; 2018 Nov; 7():. PubMed ID: 30403372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.